Key Takeaways
Medical director income in Arizona — what it pays and what it demands.
  • 2026 Arizona FMV bands: $500–$1,500/month for a solo or single-service practice, $1,500–$2,500 for a single location with RN injectors or IV, and $2,500–$5,000 for multi-service medspas. Per-hour consulting runs $150–$350.
  • A realistic portfolio is three to six engagements, not twenty. That is roughly $6,000–$15,000 per month — meaningful income, but bounded by how many practices one provider can genuinely oversee.
  • It is not passive. Protocol authorship, documented chart review, availability for clinical questions, adverse-event response, and annual re-signature are the work. Fees below market usually signal none of it is happening.
  • Under A.R.S. § 32-1601, Arizona NPs can serve as medical directors for practices within NP scope — a genuine advantage over most states. But carrier and manufacturer contracts can still require a physician regardless of state law.
  • Below-FMV flat fees create legal exposure, not savings. Compensation disconnected from documented clinical duties invites characterization as payment for referrals under federal anti-kickback and fee-splitting rules.
How these numbers were produced

Figures here are ranges, not survey data. They come from three places: publicly available salary aggregators and BLS occupational data for Arizona; the per-treatment pricing we publish on our own training and directorship pages; and profit-and-loss structures from Arizona practices I have worked with directly as a consultant and medical director. They are directional and will not match any individual practice. Treat them as a framework for your own modeling, not a forecast. Nothing here is financial, tax, or legal advice.

Why this question is asked badly

Nurse practitioners considering directorship usually ask what it pays. The more useful question is what it pays per hour of real obligation, because the answer determines whether an engagement is worth taking and whether the fee you are quoted is defensible.

Directorship is marketed in some corners as passive income — sign an agreement, collect monthly. That framing is exactly what Arizona regulators have begun scrutinizing, and it is how providers end up personally exposed for a practice they never meaningfully oversaw.

What Arizona directorship pays in 2026

Engagement profileMonthly rangeWhat it typically includes
Solo NP / single service$500–$1,500One service-line protocol set, GFE workflow, quarterly chart-review sample
Single location, RN injectors or IV$1,500–$2,500Zone-specific orders per RN, Level II & III protocols, monthly chart review
Multi-service medspa$2,500–$5,000Per-line libraries, Board of Pharmacy sourcing verification, quarterly audit
Per-hour consulting$150–$350/hrProtocol review, adverse-event consultation, audit response
Flat-fee broker placements~$799 flatSignature and availability; protocol authorship generally not included

Those bands match what we publish on our own directorship page and in the cost benchmark, because quoting one set of numbers to practices and a different set to prospective directors would be dishonest.

What a realistic portfolio looks like

The arithmetic tempts people. Six engagements at $2,000 is $12,000 a month. Twenty would be $40,000. The second number is fantasy, and pursuing it is how directors end up in front of a board.

Each engagement carries genuine recurring work: authoring and updating protocols as the practice adds services, documented chart review on a defined cadence, availability during operating hours for clinical questions, adverse-event response, and annual protocol re-signature. Done properly that is several hours per practice per month, concentrated unpredictably around incidents.

Three to six engagements is a realistic ceiling for a provider who is also practicing clinically — roughly $6,000–$15,000 monthly. A director carrying fifteen practices is either not practicing, or not overseeing.

Worth knowing
The question that ends most directorship conversations

If one of your practices had a vascular occlusion at 6:40pm on a Friday, could you name the RN, recall their delegation scope, and be reachable inside fifteen minutes? For every practice you cover? That is the honest capacity test, and it is a much lower number than the spreadsheet suggests.

Fair market value is a floor as well as a ceiling

Most providers think of FMV as a cap. In this category the bigger risk is the floor. A fee conspicuously below market and disconnected from documented duties can be characterized as payment for referrals or as a scheme to create the appearance of oversight — implicating federal anti-kickback and fee-splitting rules. Charging too little is a compliance problem, not a competitive advantage.

Your agreement should document duties, not just a fee

A defensible engagement letter specifies protocol authorship, chart-review cadence, availability expectations, QA participation, and complaint response — and prices FMV against them. If your agreement says only “serve as medical director for $X per month,” it does not describe work, and that is precisely what an investigator will notice.

Scope limits apply regardless of full practice authority

A.R.S. § 32-1601 lets an Arizona NP serve as clinical authority for practices operating within NP scope. It does not let you oversee procedures outside your scope, and it does not override a malpractice carrier or device manufacturer that contractually requires a physician. Confirm your own carrier covers directorship activity in writing — many policies do not by default.

What makes an engagement worth taking

After several years of this, the engagements that work share three traits. The practice has a realistic service menu you can actually oversee. The owner treats you as clinical infrastructure rather than a signature. And the fee reflects the documentation burden rather than the practice's budget.

The ones that go badly share one trait: the owner wanted a name on a form. Those are the engagements where you discover, during an investigation, that an RN was performing procedures your protocols never authorized.

If you are considering it

Directorship is a good fit for an established Arizona NP with real clinical depth in the services being overseen, malpractice coverage that explicitly includes directorship, and the discipline to decline practices they cannot properly supervise. It is a poor fit as passive income, and the providers who treat it that way are the reason the category is under scrutiny.

If you want to see the buyer's side of this market — what practices are being offered and at what price — our comparison of Arizona medical director options lays out every model including the flat-fee brokers.

Frequently asked

The rest of this series
Arizona aesthetic earnings — the full picture